Medscience Distribution Ltd in Wildmere Ind Estate, OX16 3TB

Description

Data updated on: 01-11-2023

Medscience Distribution Ltd with Companies House Reg No. 02491098 has been a part of the business world for 34 years. This particular Private Limited Company can be contacted at Cephalon House, Unit 8 Manor Park, Wildmere Ind Estate and their post code is OX16 3TB. This firm changed its business name two times. Until 2023 the company has provided the services it specializes in as Pharmed Uk but now the company is listed under the name Medscience Distribution Ltd. The company's declared SIC number is 86900: Other human health activities. Medscience Distribution Limited reported its latest accounts for the period up to 2022-06-30. The business most recent annual confirmation statement was filed on 2023-04-11.

There is a number of three directors controlling this particular limited company at present, including Dara M., Declan D. and John G. who have been doing the directors assignments since 2012. To find professional help with legal documentation, this particular limited company has been utilizing the skillset of Dara M. as a secretary since the appointment on 2018-03-21.

Previous company's names
Medscience Distribution Ltd 2023-02-01
Pharmed Uk Limited 2018-08-21
Neurotechnics Limited 1990-04-10

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2021-06-30	2022-06-30	2023-06-30
Currency
Net Worth	469 190	527 018	546 651	618 415	576 307

Balance Sheet
Cash Bank On Hand					4 823	4 061	214 646	200 967	233 815	464 235	254 583	647 005
Current Assets	1 579 599	1 615 073	1 472 192	1 443 978	1 876 671	1 851 275	2 267 357	4 012 139	5 103 101	5 452 930	4 730 394	8 529 857
Debtors	461 819	356 032	384 172	548 245	733 267	835 851	1 070 238	2 335 210	3 076 775	3 018 738	2 948 993	5 489 123
Net Assets Liabilities					576 307	545 334	650 542	765 540	829 203	1 272 717	2 615 299	2 836 503
Other Debtors					3 186	534	866			248 992	1 875	430 437
Property Plant Equipment					158 126	355 032	324 544	212 471	322 109	293 126	209 089	181 342
Total Inventories					1 138 580	1 011 363	982 473	1 475 962	1 792 511	1 969 957	1 526 818	2 393 729
Cash Bank In Hand	6 253	36 523	8 600	647	4 824
Intangible Fixed Assets	52 047	48 747	45 447	42 147	38 843
Net Assets Liabilities Including Pension Asset Liability	469 190	527 018	546 651	636 927	576 307
Stocks Inventory	1 111 527	1 222 517	1 079 420	913 598	1 138 580
Tangible Fixed Assets	19 369	61 312	130 383	138 571	158 126

Capital & Reserves
Called Up Share Capital	255 000	368 750	368 750	368 750	368 750
Profit Loss Account Reserve	214 190	158 268	177 901	268 177	238 637
Shareholder Funds	469 190	527 018	546 651	618 415	576 307

Other Financial Data
Audit Fees Expenses					4 500	4 500	4 500	5 443	5 000	7 526	6 000	7 000
Accumulated Amortisation Impairment Intangible Assets					27 243	30 547	33 849	66 086	132 106	254 762	324 887	409 074
Accumulated Depreciation Impairment Property Plant Equipment					222 567	209 824	265 488	289 089	327 829	382 834	475 856	557 929
Additions Other Than Through Business Combinations Intangible Assets									1 053 878
Additions Other Than Through Business Combinations Property Plant Equipment						248 537	66 300	26 438	180 525	102 775	8 983	54 328
Administration Support Average Number Employees					8	8	7	4	5	6	11	11
Amortisation Expense Intangible Assets					3 304	3 303	3 301	32 237	66 020	134 719	84 187	84 188
Amounts Owed By Related Parties					281 206	297 479	362 069	760 637	976 923			785 431
Amounts Owed To Related Parties					298 522	423 424	571 961	809 190	901 783	1 004 766	462 797
Applicable Tax Rate							19	19	19	19	19	19
Average Number Employees During Period					20	19	14	16	27	27	38	43
Balances With Banks					4 646	3 337	214 094	200 716	233 798	464 235	254 583	647 005
Bank Borrowings Overdrafts					-83 552	-14 938		-75
Bank Overdrafts					83 552	14 938		75
Cash Cash Equivalents					4 823	4 061	214 646	200 967	233 815	464 235
Cash Cash Equivalents Cash Flow Value					-94 596	-78 729	-10 877	214 646	233 815	464 235	254 583
Cash Flows From Disposal Or Reduction In Control Over Subsidiaries Or Other Businesses										25 744		130 000
Cash Flows Used In Acquiring Or Obtaining Control Subsidiaries Or Other Businesses Classified As Investing Activities								-91 478	-70 000	-1 556 848	-15 000	-2 726 538
Cash On Hand					177	724	552	251	17
Comprehensive Income Expense					-38 615	-40 529
Creditors					33 551	53 316	64 160	161 520	563 494	3 223 903	1 209 280	6 518 106
Current Tax For Period								30 860	7 743	73 482	70 089
Deferred Income										2 339 131	707 131	3 769 784
Deferred Tax Expense Credit Relating To Changes In Tax Rates Or Laws								-3 340	-34 371
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences					4 874	11 003	-3 771	-3 340	20 523	-3 003	-14 645	-4 359
Deferred Tax Liabilities					21 681	32 685	28 914	25 575	46 097	43 094	28 450	24 090
Depreciation Amortisation Expense					58 971	50 525	89 123	109 464	136 906	260 079	177 207	166 261
Depreciation Expense Property Plant Equipment					55 667	47 222	85 822	77 227	70 886	125 360	93 020	82 073
Disposals Decrease In Amortisation Impairment Intangible Assets										-12 063	-14 063
Disposals Decrease In Depreciation Impairment Property Plant Equipment						-59 964	-30 158	-53 603	-32 146	-70 355
Disposals Intangible Assets										-155 754	-56 250
Disposals Property Plant Equipment						-64 374	-41 124	-114 888	-32 147	-76 753
Finance Lease Liabilities Present Value Total					33 551	53 316	64 160	41 520	35 744	44 544	36 983	35 322
Financial Liabilities								120 000	527 750	776 080	430 440	2 713 000
Fixed Assets	71 416	110 059	175 830	180 718	196 969	390 571	356 782	468 949	1 576 445	3 113 422	2 938 010	7 773 054
Further Revenue Item Component Total Revenue										45 848
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables					-180 227	-21 396	-53 066	-924 724	-1 118 702	320 828	72 667	-1 804 126
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables					93 536	86 311	169 797	866 404	525 279	918 886	-69 745	1 754 699
Gain Loss In Cash Flows From Change In Deferred Items										2 339 131
Gain Loss In Cash Flows From Change In Inventories					224 982	-127 217	-28 890	493 489	316 549	177 446	-443 139	866 911
Gain Loss On Disposal Investments In Subsidiaries Associates Joint Ventures										-240 734
Gain Loss On Disposals Intangible Assets										-143 691	-42 187
Gain Loss On Disposals Property Plant Equipment					-319	8 651		19 553	500	-6 398
Income From Shares In Group Undertakings										204 146
Income Taxes Paid Refund Classified As Operating Activities					4 494				21 260	7 817	57 278	25 730
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation					15 867	67 852	225 523	-13 754	32 922	230 420	-209 652	392 422
Increase Decrease In Stocks Inventories Finished Goods Work In Progress					224 982	-127 217	-28 890	491 070	316 550	179 865	-443 139	866 913
Increase From Amortisation Charge For Year Intangible Assets						3 304	3 301	32 237	66 020	134 719	84 188	84 187
Increase From Depreciation Charge For Year Property Plant Equipment						47 221	85 822	77 227	70 886	125 360	93 020	82 073
Increase From Impairment Loss Recognised In Profit Or Loss Intangible Assets							3 301	32 238
Intangible Assets					38 843	35 539	32 238		987 858	709 448	583 073	498 886
Intangible Assets Gross Cost					66 086	66 086	66 086	66 086	1 119 964	964 210	907 960	907 960
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings					3 416	3 936	4 303	2 524	2 993	519	358	19
Interest Expense On Obligations Under Finance Leases Hire Purchase Contracts					5 317	4 650	6 649	7 139	5 517	15 727	9 942	8 846
Interest Payable Similar Charges Finance Costs					18 346	15 688	23 682	28 086	48 962	55 999	21 359	67 052
Interest Received Classified As Investing Activities										204 146
Interest Received Classified As Operating Activities										204 146
Investments Fixed Assets								256 478	266 478	2 110 848	2 145 848	7 092 826
Investments In Subsidiaries								256 478	266 478	2 110 848	2 145 848	7 092 826
Net Cash Flows From Used In Financing Activities					208 644	228 678	151 068	192 932	248 497	2 751 409	-1 999 544	3 986 262
Net Cash Flows From Used In Investing Activities					-75 541	-235 476	-55 334	-37 078	-683 538	-1 754 128	-294 157	-2 676 662
Net Cash Flows From Used In Operating Activities					-117 236	74 650	129 789	-169 608	467 964	-766 861	2 084 049	-917 178
Net Cash Generated From Operations					-112 742	74 650		-169 608	489 224	-759 044	2 141 327	-891 448
Net Cash Inflow Outflow From Operations Before Movements In Working Capital					25 549	12 348	217 630	265 561	212 350	658 116	1 701 110	-73 964
Net Current Assets Liabilities	726 666	786 788	595 191	528 263	434 570	240 764	386 834	483 685	-137 651	1 426 292	915 019	1 605 645
Nominal Value Allotted Share Capital						368 750	368 750	368 750	368 750	368 750	368 750	368 750
Number Shares Issued Fully Paid					368 750	368 750	368 750	368 750	368 750	368 750	368 750	368 750
Operating Profit Loss					43 576	36 687	241 312	313 200	261 812	564 026	1 680 282	-6 912
Other Comprehensive Income Expense Net Tax						9 556	-27 070	-33 132	15 985	302 633	-83 690	457 070
Other Creditors					38 801			45 000	207 896	187 998	274 510	316 594
Other Departments Average Number Employees					1	1	1	1	1	2	12	16
Other Finance Costs					9 613	7 102	12 730	18 423	40 452	39 753	11 059	58 187
Other Inventories					1 138 580	1 011 363	982 473	1 475 962	1 792 511	1 969 957	1 526 818	2 393 729
Other Operating Expenses Format2					605 027	640 399	594 106	752 291	1 145 851	1 730 860	897 199	1 092 930
Other Operating Income Format2											1 260 001	-40 335
Other Payables Accrued Expenses					84 275	43 061	101 822	206 983	190 335	154 440	140 500	365 864
Other Remaining Borrowings					238 945	350 355	428 016	850 200	1 207 582	147 068	449 727	2 200 881
Other Remaining Operating Income											1 260 001	-40 335
Ownership Interest In Subsidiary Percent								55	55
Par Value Share				1	1	1	1	1	1	1	1	1
Payments Finance Lease Liabilities Classified As Financing Activities						-917	16 530	-34 781	-1 177	90 253	-44 544	-36 387
Pension Costs Defined Contribution Plan					31 453	23 956	24 017	26 301	23 532	48 823	38 614	47 680
Percentage Class Share Held In Subsidiary									55	100	100	100
Prepayments					56 263	63 148	51 185	55 764	86 446	249 988	174 083	478 711
Proceeds From Finance Leases Classified As Financing Activities					16 709	-917
Proceeds From Loans Advances From Subsidiaries Classified As Financing Activities										1 382 539	-2 257 659	2 271 495
Proceeds From Sales Intangible Assets										155 754
Proceeds From Sales Property Plant Equipment						13 061	10 966	80 838	500
Profit Loss					-38 615	-40 529	132 278	148 130	47 678	140 881	1 426 272	-235 866
Profit Loss On Ordinary Activities Before Tax					-33 741	-29 526	128 507	175 650	75 944	211 360	1 481 716	-240 225
Property Plant Equipment Gross Cost					380 693	564 856	590 032	501 560	649 938	675 960	684 943	739 271
Provisions For Liabilities Balance Sheet Subtotal					21 681	32 685	28 914	25 574	46 097	43 094	28 450	24 090
Purchase Intangible Assets									-433 513	-324 395	-270 174	-25 796
Purchase Property Plant Equipment					-75 541	-248 537	-66 300	-26 438	-180 525	-102 775	-8 983	-54 328
Raw Materials Consumables Used					1 840 511	1 581 281	2 047 043	3 919 600	6 446 109	10 523 100	7 406 112	11 907 686
Repayments Borrowings Classified As Financing Activities						111 410	77 661	422 184	357 381	-1 060 514	302 659	1 751 154
Revenue From Sale Goods					3 002 578	3 068 023	3 462 331	5 237 486	8 371 204	14 204 385	10 384 173	13 754 258
Selling Average Number Employees					11	10	6	11	21	19	15	16
Social Security Costs					74 114	61 575	50 049	63 360	73 297	136 233	125 300	181 943
Staff Costs Employee Benefits Expense					738 446	682 439	550 980	743 465	833 982	1 612 112	1 217 442	1 587 132
Taxation Social Security Payable					63 838	76 842	88 585	109 068	174 963	192 560	249 450	192 345
Tax Decrease From Utilisation Tax Losses							-28 187	-6 666
Tax Expense Credit Applicable Tax Rate							24 416	33 373	14 429	73 482	70 089
Tax Increase Decrease From Effect Capital Allowances Depreciation								3 340	34 371
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss								813	13 837
Tax Increase Decrease From Other Tax Effects Tax Reconciliation									13 837	-3 003	-14 645	-4 359
Tax Tax Credit On Profit Or Loss On Ordinary Activities					4 874	11 003	-3 771	27 520	28 266	70 479	55 444	-4 359
Total Assets Less Current Liabilities	798 082	896 847	771 021	727 492	631 539	631 335	743 616	952 634	1 438 794	4 539 714	3 853 029	9 378 699
Total Borrowings					33 551	53 316	64 160	41 520	35 744	108 692	71 709	35 322
Total Operating Lease Payments						84 293	58 656	67 899	65 891	111 814	88 890	118 725
Trade Creditors Trade Payables					584 389	672 796	655 358	1 454 438	2 513 611	2 206 622	2 099 813	3 733 500
Trade Debtors Trade Receivables					392 611	474 690	656 118	1 518 809	2 013 406	2 519 758	2 773 035	3 794 544
Turnover Revenue					3 002 578	3 068 023	3 462 331	5 237 486	8 371 204	14 250 233	10 384 173	13 754 258
Unpaid Contributions To Pension Schemes										5 632	5 776	7 956
Wages Salaries					632 879	596 908	476 914	653 804	737 153	1 427 056	1 053 528	1 357 509
Creditors Due After One Year	328 892	369 829	210 263	73 758	33 551
Creditors Due Within One Year	852 933	828 284	877 001	915 715	1 442 101
Intangible Fixed Assets Aggregate Amortisation Impairment	14 039	17 339	20 639	23 939	27 243
Intangible Fixed Assets Amortisation Charged In Period		3 300	3 300	3 300	3 304
Intangible Fixed Assets Cost Or Valuation	66 086	66 086	66 086	66 086	66 086
Number Shares Allotted				213 750	213 750
Other Aggregate Reserves				-27 587	-31 080
Provisions For Liabilities Charges			14 107	16 808	21 681
Share Capital Allotted Called Up Paid			213 750	213 750	213 750
Tangible Fixed Assets Additions		63 032	97 894	54 985	75 541
Tangible Fixed Assets Cost Or Valuation	137 325	200 357	251 380	305 755	380 693
Tangible Fixed Assets Depreciation	117 956	139 045	120 997	167 184	222 567
Tangible Fixed Assets Depreciation Charged In Period		21 089	28 822	46 339	55 667
Tangible Fixed Assets Depreciation Decrease Increase On Disposals			46 871	153	284
Tangible Fixed Assets Disposals			46 871	611	603

Company staff

Dara M.

Role: Secretary

Appointed: 21 March 2018

Latest update: 28 March 2024

Dara M.

Role: Director

Appointed: 03 August 2012

Latest update: 28 March 2024

Declan D.

Role: Director

Appointed: 03 August 2012

Latest update: 28 March 2024

John G.

Role: Director

Appointed: 03 August 2012

Latest update: 28 March 2024

Julie F.

Role: Secretary

Appointed: 06 November 2000

Resigned: 21 March 2018

Latest update: 28 March 2024

Felicia M.

Role: Secretary

Appointed: 08 March 1999

Resigned: 06 October 2000

Latest update: 28 March 2024

David M.

Role: Director

Appointed: 13 January 1995

Resigned: 03 August 2012

Latest update: 28 March 2024

Julie F.

Role: Secretary

Appointed: 14 July 1994

Resigned: 08 February 1999

Latest update: 28 March 2024

Dennis J.

Role: Director

Appointed: 01 September 1993

Resigned: 02 September 1999

Latest update: 28 March 2024

Jane S.

Role: Secretary

Appointed: 01 September 1993

Resigned: 13 July 1994

Latest update: 28 March 2024

Ian G.

Role: Secretary

Appointed: 09 November 1992

Resigned: 01 September 1993

Latest update: 28 March 2024

Alexander M.

Role: Director

Appointed: 11 April 1992

Resigned: 16 January 1995

Latest update: 28 March 2024

Glynn R.

Role: Director

Appointed: 11 April 1992

Resigned: 09 November 1992

Latest update: 28 March 2024

Stephen W.

Role: Director

Appointed: 11 April 1992

Resigned: 09 November 1992

Latest update: 28 March 2024

Ian G.

Role: Director

Appointed: 11 April 1992

Resigned: 30 September 2015

Latest update: 28 March 2024

People with significant control

Executives who control this firm include: Dara M. has substantial control or influence over the company. John G. has substantial control or influence over the company. Declan D. has over 1/2 to 3/4 of voting rights.

Dara M.

Notified on 6 April 2016

Nature of control:

substantial control or influence

John G.

Notified on 6 April 2016

Nature of control:

substantial control or influence

Declan D.

Notified on 6 April 2016

Nature of control:

over 1/2 to 3/4 of voting rights

Accounts Documents

Account next due date	31 March 2024
Account last made up date	30 June 2022
Confirmation statement next due date	25 April 2024
Confirmation statement last made up date	11 April 2023

Annual Accounts 28 February 2013
Start Date For Period Covered By Report	2012-01-01
End Date For Period Covered By Report	2012-12-31
Date Approval Accounts	28 February 2013
Annual Accounts 10 June 2014
Start Date For Period Covered By Report	2013-01-01
End Date For Period Covered By Report	2013-12-31
Date Approval Accounts	10 June 2014
Annual Accounts 30 April 2015
Start Date For Period Covered By Report	2014-01-01
End Date For Period Covered By Report	2014-12-31
Date Approval Accounts	30 April 2015
Annual Accounts 30 June 2016
Start Date For Period Covered By Report	2015-01-01
End Date For Period Covered By Report	2015-12-31
Date Approval Accounts	30 June 2016
Annual Accounts
Start Date For Period Covered By Report	2016-01-01
End Date For Period Covered By Report	2016-12-31
Annual Accounts
Start Date For Period Covered By Report	2017-01-01
End Date For Period Covered By Report	2017-12-31
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	2018-12-31
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	2019-12-31
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	2021-06-30
Annual Accounts
Start Date For Period Covered By Report	2021-07-01
End Date For Period Covered By Report	2022-06-30
Annual Accounts
Start Date For Period Covered By Report	2022-07-01
End Date For Period Covered By Report	2023-06-30

Medscience Distribution Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Dara M.

Dara M.

Declan D.

John G.

Julie F.

Felicia M.

David M.

Julie F.

Dennis J.

Jane S.

Ian G.

Alexander M.

Glynn R.

Stephen W.

Ian G.

People with significant control

Dara M.

John G.

Declan D.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies